Advertisement

Topics

New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery

08:03 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Masimo (NASDAQ: MASI) announced today the findings of a recent study conducted on low-risk patients undergoing colorectal surgery, in which researchers assessed the utility of noninvasive and continuous Masimo PVi® (Ple...

Other Sources for this Article

Masimo
Evan Lamb, 949-396-3376
elamb@masimo.com

NEXT ARTICLE

More From BioPortfolio on "New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery"

Advertisement
Quick Search
Advertisement
Advertisement